How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

52,632 results for

Topical Paste

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis

Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis (STACCATO) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03576898 Recruitment Status : Not yet recruiting First Posted : July 3, 2018 Last

2018 Clinical Trials

82. A Randomized Trial of Topical Corticosteroid Use in Addition to Oral Antivirals for Prevention of Recurrence of Herpes Simplex Virus (HSV) Keratitis

are incarcerated. Unable to give informed consent or have an acceptable surrogate capable of giving informed consent on behalf of the subject. Persons with systemic medical problems who do not agree to have continued medical follow-up. History of topical corticosteroids to the eyelids or ocular surface of the involved eye within the prior 30 days prior to enrollment. Patients with 3 or more episodes of uveitis in the past 12 months. History of keratoplasy or keratorefractive surgery of the involved eye (...) A Randomized Trial of Topical Corticosteroid Use in Addition to Oral Antivirals for Prevention of Recurrence of Herpes Simplex Virus (HSV) Keratitis A Randomized Trial of Topical Corticosteroid Use in Addition to Oral Antivirals for Prevention of Recurrence of Herpes Simplex Virus (HSV) Keratitis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved

2018 Clinical Trials

83. Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes

Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please (...) remove one or more studies before adding more. Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes (STACCATO) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03586284

2018 Clinical Trials

84. Topical Calcipotriene Treatment for Breast Cancer Immunoprevention

Topical Calcipotriene Treatment for Breast Cancer Immunoprevention Topical Calcipotriene Treatment for Breast Cancer Immunoprevention - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Topical Calcipotriene (...) : Massachusetts General Hospital Information provided by (Responsible Party): Shadmehr Demehri, Massachusetts General Hospital Study Details Study Description Go to Brief Summary: This research study is studying a topical ointment called calcipotriene to see if it can stimulate the immune cells against the breast lesion in ways that would prevent its recurrence after surgical removal Condition or disease Intervention/treatment Phase Breast Cancer Drug: Topical Calcipotriene Ointment Other: Topical Vaseline

2018 Clinical Trials

85. A Trial to Assess the Safety and Efficacy of Topical Salbutamol in Healthy Volunteers.

A Trial to Assess the Safety and Efficacy of Topical Salbutamol in Healthy Volunteers. A Trial to Assess the Safety and Efficacy of Topical Salbutamol in Healthy Volunteers. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies (...) before adding more. A Trial to Assess the Safety and Efficacy of Topical Salbutamol in Healthy Volunteers. (SSCART) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03514615 Recruitment Status : Active, not recruiting First Posted : May 2, 2018 Last Update Posted : February 7, 2019 Sponsor: University

2018 Clinical Trials

86. Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis

Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum (...) number of saved studies (100). Please remove one or more studies before adding more. Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis (Phase2b) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our

2018 Clinical Trials

87. Topical rhThrombin as an Adjunct to Hemostasis During Segmental Hepatectomy

Topical rhThrombin as an Adjunct to Hemostasis During Segmental Hepatectomy Topical rhThrombin as an Adjunct to Hemostasis During Segmental Hepatectomy - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Topical rhThrombin as an Adjunct to Hemostasis During Segmental Hepatectomy The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03611426 Recruitment Status : Recruiting First Posted : August 2, 2018 Last Update Posted : August

2018 Clinical Trials

88. Study of the Efficacy of 532nm Laser and 1064 nm Laser in the Treatment of Cutaneous Lupus Erythematous Versus Topical Corticosteroids Alone

Study of the Efficacy of 532nm Laser and 1064 nm Laser in the Treatment of Cutaneous Lupus Erythematous Versus Topical Corticosteroids Alone Study of the Efficacy of 532nm Laser and 1064 nm Laser in the Treatment of Cutaneous Lupus Erythematous Versus Topical Corticosteroids Alone - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save (...) this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Study of the Efficacy of 532nm Laser and 1064 nm Laser in the Treatment of Cutaneous Lupus Erythematous Versus Topical Corticosteroids Alone The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your

2018 Clinical Trials

89. Efficacy and Safety Study to Compare Topical Herbal Solution and Minoxidil 5% in Male Pattern Hair Loss

: Yes Criteria Inclusion Criteria: Men 18 to 50 years old Written consent Normal general health status Men who have a presentation of androgenetic alopecia (Norwood II - V). Exclusion Criteria: Use of any topical product in the target region interfering with the study product in the last 3 months Within past 6 months receiving of chemotherapy/cytotoxic agents Clinical diagnosis of alopecia areata or other non-AGA forms of alopecia Uncontrolled hypertension Any dermatological disorders in the scalp (...) Efficacy and Safety Study to Compare Topical Herbal Solution and Minoxidil 5% in Male Pattern Hair Loss Efficacy and Safety Study to Compare Topical Herbal Solution and Minoxidil 5% in Male Pattern Hair Loss - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100

2018 Clinical Trials

90. Evaluation of Topical Application of BMX-010 in Subjects With Acne Vulgaris.

) in the past 2 weeks; Oral retinoid use (e.g., isotretinoin) within 6 months prior to baseline or vitamin A supplements greater than 10,000 units/day within 6 months of baseline; Concomitant skin disease that could confound clinical evaluations or increase risk to the subject; Use of medicated make-up (including anti-aging make-up) throughout the study; Use during the study of 1) systemic steroids, 2) topical retinoids to the face, 3) antibiotics known to impact acne, 4) immunosuppressive agents (...) Evaluation of Topical Application of BMX-010 in Subjects With Acne Vulgaris. Evaluation of Topical Application of BMX-010 in Subjects With Acne Vulgaris. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more

2018 Clinical Trials

91. Topical Bimatoprost in the Treatment of Migraine

Topical Bimatoprost in the Treatment of Migraine Topical Bimatoprost in the Treatment of Migraine - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Topical Bimatoprost in the Treatment of Migraine The safety (...) ): Manistee Partners Study Details Study Description Go to Brief Summary: The study is to assess the effectiveness of topically applied bimatoprost in reducing migraine headache frequency, severity, and duration. It will also assess the effect of topical bimatoprost on quality of life. Condition or disease Intervention/treatment Phase Migraine Disorders Headache Disorders Drug: Bimatoprost Topical Solution Drug: Control Phase 2 Detailed Description: Hall, et al. have observed retrospectively

2018 Clinical Trials

92. A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisable

Dermatitis) for at least 12 months. Have had inadequate response to existing topical (applied to the skin) medications within 6 months preceding screening. Are willing to discontinue certain treatments for eczema (such as systemic and topical treatments during a washout period). Agree to use emollients daily. Have a medical contraindication to cyclosporine, or had intolerance and/or unacceptable toxicity or inadequate response to cyclosporine in the past. Exclusion Criteria: Are currently experiencing (...) A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisable A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically

2018 Clinical Trials

93. An Evaluation of the Safety and Pharmacokinetics of Tavaborole Topical Solution for the Treatment of Fungal Disease of the Toenail in Children and Adolescents

An Evaluation of the Safety and Pharmacokinetics of Tavaborole Topical Solution for the Treatment of Fungal Disease of the Toenail in Children and Adolescents An Evaluation of the Safety and Pharmacokinetics of Tavaborole Topical Solution for the Treatment of Fungal Disease of the Toenail in Children and Adolescents - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record (...) Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. An Evaluation of the Safety and Pharmacokinetics of Tavaborole Topical Solution for the Treatment of Fungal Disease of the Toenail in Children and Adolescents The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal

2018 Clinical Trials

94. Study Evaluating the Safety, Tolerability, PK, and Activity of Topical ATx201 Gel in Outpatients With Impetigo

within the past 3 months receipt of any topical medication on the regions to be treated or topical antibiotics used for nasal decolonization within the past 24 hours Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03429595 Locations Layout table (...) Study Evaluating the Safety, Tolerability, PK, and Activity of Topical ATx201 Gel in Outpatients With Impetigo Study Evaluating the Safety, Tolerability, PK, and Activity of Topical ATx201 Gel in Outpatients With Impetigo - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved

2018 Clinical Trials

95. Diode Laser Versus Topical Corticosteroids in Management of Oral Ulcers in Behcet's Disease

Intervention/treatment Phase Autoimmune Behcet Syndrome Radiation: Diode laser 980nm&100 mWatt Drug: Triamcinolone Acetonide Not Applicable Detailed Description: The enrolled patients will be divided randomly into two groups.one group will receive Diode Laser (power:100 milli Watt,wavelength:980 mmm, delivery system:biostimulation probe) and other group will receive topical corticosteroids(Kenacort A Orabase: triamcinolone acetonide 0.1% 5 gram adhesive paste - Dermaphor) four times daily. Study Design Go (...) : Active Control,Randomized,Double- Blinded Clinical Trial of BD Estimated Study Start Date : February 25, 2019 Estimated Primary Completion Date : February 25, 2019 Estimated Study Completion Date : February 25, 2019 Resource links provided by the National Library of Medicine related topics: related topics: available for: resources: Arms and Interventions Go to Arm Intervention/treatment Active Comparator: Triamcinolone acetonide Triamcinolone acetonide 0.1% 5 gm adhesive paste 4 times / day for 1

2018 Clinical Trials

96. Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis Who Are Not Adequately Controlled With or Have Contraindications to Oral Cyclosporine A

Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis Who Are Not Adequately Controlled With or Have Contraindications to Oral Cyclosporine A Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis Who Are Not Adequately Controlled With or Have Contraindications to Oral Cyclosporine A - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration (...) or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis Who Are Not Adequately Controlled With or Have Contraindications to Oral Cyclosporine A (ECZTRA 7) The safety and scientific validity of this study is the responsibility of the study sponsor

2018 Clinical Trials

97. Topical Paste

Topical Paste Topical Paste Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Topical Paste Topical Paste Aka: Topical Paste From (...) Related Chapters II. Preparations or ( , , or ) III. Indications Wet intertriginous rashes IV. Disadvantages Need oil to wipe off (not removed with water) Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Topical Paste." Click on the image (or right click) to open the source website in a new browser window. Related Studies (from Trip Database) Related Topics in Pharmacology About FPnotebook.com is a rapid access, point-of-care

2015 FP Notebook

98. Using ‘real life’ analogies to get past scientific uncertainty on climate change

Using ‘real life’ analogies to get past scientific uncertainty on climate change Using 'real life' analogies to get past scientific uncertainty on climate change | PLOS Blogs Network PLOS Blogs Staff Blogs Blogs by Topic Biology & Life Sciences Earth & Environmental Sciences Multi-disciplinary Sciences Medicine & Health Research Analysis & Scientific Policy Diverse perspectives on science and medicine Staff Blogs Blogs by Topic Biology & Life Sciences Earth & Environmental Sciences Multi (...) these similarities between climate change and medical diseases: Risks are often caused or aggravated by human behavior. Processes are often progressive. Produce symptoms outside the normal range of past experience. Uncertainties in prognosis of future events. Treatment often involves trade offs, or side-effects. Most effective approach is often to treat the underlying problem, instead of just alleviating symptoms. Hard to reverse. Image by Takver, Flickr Compared to people who read about the courtroom or natural

2017 PLOS Blogs Network

99. On North Korea, Past Foreign Policy Fiascoes Show U.S. What Not to Do

On North Korea, Past Foreign Policy Fiascoes Show U.S. What Not to Do On North Korea, Past Foreign Policy Fiascoes Show U.S. What Not to Do | RAND Objective Analysis. Effective Solutions. Site-wide navigation Trending Topics Featured Research Activities Spotlight Commentary: Commentary: By Research Area Drawing upon decades of experience, RAND provides research services, systematic analysis, and innovative thinking to a global clientele that includes government agencies, foundations

2017 The RAND blog

100. Why Pockets and Waves of De-Feminization in Science’s Past Matter Now

Why Pockets and Waves of De-Feminization in Science’s Past Matter Now Why Pockets and Waves of De-Feminization in Science's Past Matter Now | Absolutely Maybe PLOS Blogs Staff Blogs Blogs by Topic Biology & Life Sciences Earth & Environmental Sciences Multi-disciplinary Sciences Medicine & Health Research Analysis & Scientific Policy Diverse perspectives on science and medicine Staff Blogs Blogs by Topic Biology & Life Sciences Earth & Environmental Sciences Multi-disciplinary Sciences Medicine (...) American botany, not a single woman is mentioned. The Botanical Society of America was formed in 1893, emerging from an interest group of the American Association for the Advancement of Science (AAAS), with woman among the charter members. has photos of their past presidents. When you scroll up from the bottom, it’s row after row after row of (white) men. With a couple of exceptions, it takes nearly a century for women to be equal (still all white). From the vantage point of that , the rise of women

2017 Absolutely Maybe

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>